SCHEMBL7093702

SCHEMBL7093702

O/N=C1\c2ccccc2-c2[nH]nc(-c3ccccc3)c21

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNE2 O96020 4/20 0.45
CCNE1 P24864 4/20 0.45
CDK2 P24941 4/20 0.45
CDK4 P11802 3/20 0.45
CCND1 P24385 3/20 0.45
KDR P35968 1/20 0.44
ALDH1A1 P00352 5/20 0.44
KDM4E B2RXH2 4/20 0.44
GAA P10253 3/20 0.44
HPGD P15428 2/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
HSD17B10 Q99714 1/20 0.44
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.43
KMT2A Q03164 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7093703 1.00 CCNE2 (0.45) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL7092321 0.88 CDK4 (0.48) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL20035506 0.81 ALDH1A1 (0.53) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL7090322 0.79 PDE4A (0.49) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL7090323 0.79 PDE4A (0.49) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL7090159 0.76 CDK4 (0.71) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL22825318 0.73 CDK4 (0.46) CCNE2CCNE1CDK2CDK4CCND1
SCHEMBL5231898 0.70 KDM4E (0.62) KDRALDH1A1KDM4EGAAHPGD
SCHEMBL16433027 0.67 KDM4E (0.58) KDRALDH1A1KDM4EGAAHPGD
SCHEMBL8081940 0.66 ALDH1A1 (0.50) CDK2ALDH1A1KDM4EGAAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1289525-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS Abbott GmbH & Co. KG (DE) 2003-03-12 EP disclosed
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed
WO-2001087846-A2 TRICYCLIC PYRAZOLE DERIVATIVES AS PROTEIN KINASE INHIBITORS ABBOTT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG & COMPANY KOMMANDITGESELLSCHAFT (DE) 2001-11-22 WO disclosed
EP-1127051-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2001-08-29 EP disclosed
WO-2000027822-A2 TRICYCLIC PYRAZOLE DERIVATIVES BASF AKTIENGESELLSCHAFT (DE) 2000-05-18 WO disclosed